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The cDNA for a third &subunit of the rat GABA* receptor has been cloned using another p-subunit, which we had previously cloned [(1989) 
FEBS Lett. 246, 145-1481, as a probe.. The N 8-kb cDNA for this p-subunit (termed ,92) encodes a protein of 474 amino acid residues that shares 
-80% sequence identity with the rat and bovine /?l- and /?3-subunits. Coexpression of the cloned j&subunit cDNA with the al-subunit cDNA 
of the rat GABA* receptor in Xenopus oocytes produced a functional receptor and Cl- channel with pharmacological characteristics of a GABAA 
receptor. In contrast to interchanging a-subunits [(1988) Nature 335, 76791, exchange of /?2- or j&subunits in an al/B receptor complex did not 
markedly alter the pharmacological properties of expressed receptors. In situ hybridization histochemistry with synthetic subunit-specific oligo- 
deoxynucleotide probes revealed a region-specific expression of al-, /X2- and @3-subunit mRNAs in the rat central nervous system. These observa- 
tions provide an additional molecular basis for the functional heterogeneity in the GABA,, receptor complex. 
Receptor subtype; cDNA cloning; Expression; Hybridization histochemistry, in situ; (Xenopus oocyte) 
1. INTRODUCTION 
The y-aminobutyric acid (GABAA) receptor is a 
ligand-gated Cl- channel through which GABA and the 
anxiolytic benzodiazepines mediate many of their ef- 
fects (for a review, see [l]). Both benzodiazepines and 
barbiturates potentiate the increase in neuronal hyper- 
polarization underlying the inhibition mediated by 
GABA in the CNS. Biochemical evidence indicates that 
the binding sites for benzodiazepines and muscimol (a 
GABAA agonist) reside in two major proteins, the (Y- 
and &subunits, respectively, of the purified GABAA 
receptor complex [2-51. Recently, the primary struc- 
tures of the bovine GABAA receptor LY- and &subunit 
have been deduced from cloned complementary DNAs 
[6,7]. To date, bovine cDNAs encoding three different 
a-subunit subtypes (designated l-3) have been isolated 
[7], providing evidence for the concept of GABAA 
receptor heterogeneity. Coexpression of any a-subunit 
with a single bovine P-subunit in mammalian cells or 
Xenopus oocytes results in GABAA receptors which 
display many of the pharmacological properties of their L 
neural counterparts, including potentiation by bar- 
biturates. Furthermore, the three a-subunits are dif- 
ferentially expressed in brain and produce, when ex- 
pressed with the bovine@-subunit n vitro, receptor sub- 
types which can be distinguished by their apparent sen- 
sitivity to GABA [7-lo]. 
We have previously described the cDNAs encoding 
the al- and a&subunit of the rat GABAA receptor [ 111. 
Based on amino acid sequence identity, our rat fl- 
subunit and the bovine &subunit were not equivalent. 
In the same study, we also reported the isolation of a 
clone for a third P-subunit. More recently, cDNAs en- 
coding the rat equivalent of the bovine ,&l-subunit and 
a third rat P-subunit have been identified [ 121. To keep 
the nomenclature for these multiple &subunits clear, 
we have termed our previously published P-subunit 
(clone @a; [ 1 l]), ,&3, as was subsequently described in 
[ 121. Here we report the pharmacological characteriza- 
tion of the third P-subunit, termed p2 to be consistent 
with the terminology of Ymer et al. [12]. In this report 
we show that, while the rat p2- and P3-subunits are dif- 
ferentially expressed in the brain, the receptor com- 
plexes formed when each of these P-subunits is coex- 
pressed with the rat al-subunit in Xenopus oocytes do 
not differ in their sensitivity to GABA. 
2. MATERIALS AND METHODS 
I. 1. Isolation and sequencing of cDNA clones 
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An adult rat cortex cDNA library constructed in the pcDV1 plasmid 
vector was used [I 11. Recombinants (- 7 x 106) were screened by 
Southern blot analysis [13] at moderate stringency (hybridizing and 
washing in 3 x SSC at 60°C) using as a probe a “P-labeled 1.5kb 
Nnrl-&al fragment from the rat GABAA P3-subunit clone, RC,62a 
Ill]. Four clones distinct from previously described&subunits [6, I l] 
were isolated, one of which, an - 8-kb clone (RC@5e), was determin- 
ed to be full-length by restriction and sequence analysis. Overlapping 
restriction fragments were isolated, subcloned into M13, and sequenc- 
ed in both directions by the Sanger chain-termination method [ 141 us- 
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ing the modified T7 polymerase [15] (Sequenase; US Biochemical 
Corp., Cleveland, OH). 
2.2. Expression of rat GABA* receptor subunit mRNA in Xenopus 
oocytes 
Preparation of pGEM-7Zf( +) plasmid vectors (Promega, 
Madison, WI) for in vitro RNA transcription of the cul- and 
/X2-subunit cDNAs of the rat GABAA receptor has been previously 
described [ 111. The entire coding sequence for the m-subunit cDNA 
(clone RCPSe) contained within a 1.85-kb BamHI-Xbal fragment was 
similarly subcloned into pGEM-7Zf( +). Since there were no conve- 
nient restriction sites in the 78-bp 5’-untranslated sequence of this 
cDNA, the BamHI site in the intron of the SV40 promoter region of 
the pcDV1 vector (IOl-bp upstream from the PstI site which normally 
defines the 5’ end of a cDNA) was used; the XbaI site is 307-bp 
downstream from the stop codon in the 3’-untranslated sequence of 
the cDNA. Capped RNA transcripts were obtained from linearized 
templates using SP6 polymerase and 7mG(5 ‘)ppp(5 ‘)G according to 
the manufacturer’s instructions. Transcripts were mixed as indicated 
at a final concentration of 250-300 ng/ml and - 50 nl was injected in- 
to each oocyte (defolliculated). Oocytes were maintained in Modified 
Barth’s solution, pH 7.4 (MBS) [la] containing penicillin and strep- 
tomycin at 18°C and assayed for GABA-induced Cl- current at 72-96 
h. All currents were recorded at a voltage-clamped potential of - 60 
mV. Drugs were applied by bath perfusion over 2 min to ensure 
saturating responses. Antagonists or potentiating drugs were applied 
at the indicated concentrations 1.5-2 min prior to the addition of 
GABA. To avoid the prolonged desensitization observed after ap- 
plications of high doses of GABA, oocytes were perfused with MBS 
for 20 min between applications. In general, individual oocytes were 
carried through each series of drug applications as indicated. Data 
shown are representative of those obtained with 2-3 oocytes using dif- 
ferent batches of synthetic subunit-specific mRNAs. ECsss in dose- 
response xperiments were determined from pooled, normalized data 
by non-linear least-squares regression analysis according to Mar- 
quardt algorithms using a commercially available data analysis soft- 
ware (GraphPAD InPlot, San Diego, CA). 
2.3. Probes 
Oligodeoxynucleotide probes were synthesized on an Applied Bio- 
systems 380A DNA Synthesizer. For each rat GABAA receptor 
subunit two 48-bp probes complementary to mRNA sequences en- 
coding segments of the putative signal peptides and cytoplasmic do- 
mains ((111 and this report) were prepared. The probes were com- 
plementary to sequences encoding amino acids - 3 to 13 @la) and 
323-338 (cylb), - 23 to - 8 ma) and 325-340 @2b), and - 23 to - 8 
@3a) and 325-340 @3b) of the rat al-, ,fX?- and fl3-subunits, respec- 
tively. As a control for non-specific labeling, two synthetic message 
sense probes, exactly complementary to the crib and fib-subunit an- 
tisense probes, were also prepared. Probes were labeled on their 
3 ’ -ends with deoxyadenosine triphosphate in the cy position with ‘?S 
(1300 Ci/mmol, New England Nuclear) for in situ hybridization 
histochemistry using terminal deoxynucleotidyl transferase (Bethesda 
Research Laboratories) to a specific activity between 3500-5000 
Ci/mmol. 
2.4. In situ hybridization histochemistry 
Serial 12-pm sections of adult, male rat brains were cut on a 
cryostat microtome at - 18°C thaw-mounted onto twice-gelatin- 
coated slides and stored at - 80°C until hybridization. The overall 
procedure for in situ hybridization histochemistry has been outlined 
in detail [17]. ‘?S-Labeled probe (l-2 x lo6 dpm in 45 pl hybridiza- 
tion buffer containing 4 x SSC, 50% formamide, 1 x Denhardt’s, 
10% dextran sulfate, 250pg/ml yeast RNA, 5OOfig/ml herring sperm 
DNA and 0.1 M dithiothreitol) was applied to the sections for 18 h at 
37°C. After hybridization the sections were washed 4 X 15 min at 
55°C in 1 x SSC followed by 2 x 1 h washes at room temperature, 
rinsed quickly in distilled water, dried and exposed to Hyperfilm- 
/3max (Amersham) for 1 week at room temperature. 
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3. RESULTS AND DISCUSSION 
The nucleotide and deduced amino acid sequence of 
clone RC,&Se (data not shown) are identical to the 
recently published rat ,&2-GABA* receptor subunit [ 121. 
The predicted amino acid sequence shows 80% identity 
with the bovine [6], rat [ 11,121 and human [ 191 GABAA 
receptor fll- and fl3-subunits, but only 30-40% amino 
acid identity with the GABAA receptor al-3-subunits 
[7,11]. Sequence similarity between the @subunits is 
highest in the 4 hydrophobic putative membrane- 
spanning domains, M 1 -M4. In contrast, the extreme N- 
terminal signal peptides and the sequence between M3 
and M4 are quite divergent. For example, of the 97 
amino acid differences found between the rat ,&2- and 
fl3-subunit sequences, 55 (57%) occur in the M3-M4 
loop. 
Injection of synthetic rat al mRNA in combination 
with either synthetic rat P-subunit mRNA produced 
functional Cl- channel complexes in the oocyte mem- 
brane (fig. 1A). Response to the addition of GABA was 
immediate and sustained at low doses (generally 
<EC& however, at higher doses both subunit com- 
binations exhibited marked desensitization during 
agonist perfusions. Injection of @-subunit mRNA 
alone did not produce a detectable GABA response; 
this was also true of rat (Al- and P3-subunit transcripts 
[ll]. The response to GABA in oocytes expressing 
al/@- or al/P3-subunits was markedly attenuated in 
the presence of the GABA* antagonist, bicuculline 
(fig. 1A). Similar results (data not shown) were observed 
in the presence of picrotoxin (5 PM) which specifically 
blocks Cl- conductance through the GABAA receptor 
complex. Barbiturates, such as sodium pentobarbital, 
have been shown to enhance the actions of GABA by 
increasing mean channel opening time [19]. Pentobar- 
bital (10 PM) potentiated GABA-stimulated Cl- con- 
ductance approximately 5-6-fold in oocytes expressing 
cul/pZ or cul/,f33 (fig.lA). This concentration of pen- 
tobarbital alone caused little (c 10 nA) or no Cl- con- 
ductance. Higher concentrations of pentobarbital 
(25-50 PM) directly stimulated Cl- conductance (data 
not shown), as has also been shown for cultured spinal 
neurons [20] and cloned bovine GABAA receptor 
subunits [7,8]. In oocytes with either subunit combina- 
tion the threshold of sensitivity for potentiation was - 1 
PM pentobarbital which caused a 1.5-2-fold increase in 
conductance (data not shown). In contrast, no signifi- 
cant enhancement of the GABA response was observed 
with diazepam (lo-50 PM; data not shown). al/P2 or 
cull/33 heteromeric receptors displayed an identical rank 
order of agonist-stimulated Cl- conductance as 
previously demonstrated for native CNS GABAA recep- 
tors [21]. At equivalent doses, muscimol was more po- 
tent than GABA in increasing Cl- current with either & 
subunit tested (fig.lB). Isoguvacine, an additional 
GABAn agonist, was less potent than GABA while the 
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Fig.1. (A) Expression of cloned GABAn receptors in Xenopus 
oocytes injected with either cul/fl (left) or (rl/fl3 (right) synthetic 
mRNAs. Response to GABA (solid bars) was measured at a voltage- 
clamped membrane potential of - 60 mV. Concentrations of GABA 
in the bath perfusion (1 .O ,uM for al/&! and 0.5 CM for cul/,83) were 
chosen to generate quivalent amplitudes of Cl- current based upon 
the slight differences in sensitivity to GABA. For blockade of 
response to GABA, 5 PM bicuculline methobromide (top) was ap- 
plied 1 S-2 min prior to the addition of GABA. For potentiation of 
response to GABA (bottom), 10 PM pentobarbitol was similarly per- 
fused prior to the addition of GABA. (B) Agonist-stimulated increase 
in Cl- current in cloned GABAA receptors expressed in Xenopus 
oocytes. Oocytes expressing either cul/fl- (top) or cul/p3- (bottom) 
subunits were perfused for 2 min (solid bar) in the presence of the 
GABAa agonist, baclofen (B), GABA (G), or the GABAA-selective 
agonist isoguvacine (I) and muscimol (M). The concentrations of 
agonists applied were 1.0 FM and 0.5 pM for al/p2 and c~l/,83, 
respectively. 
GABAn agonist, baclofen, was without effect. (ul/,&- 
and al/P3-subunit combinations displayed similar sen- 
sitivities to GABA (fig.2). The ECSOS for GABA- 
stimulated increases in Cl- conductance in oocytes ex- 
pressing al/p2 and (rl/fl3 were 5.8 ,uM (n = 3) and 4.3 
PM (n = 4), respectively; Hill coefficients for both cu/fl 
combinations were identical, slope = 1.1 + 0.1. Thus, 
while the ,&2- and /33-subunit cDNAs encode proteins 
capable of forming GABAA receptor complexes with 
the al-subunit, interchanging the &subunits does not 
produce distinguishable differences in the pharma- 
cological properties of these complexes when expressed 
in oocytes. 
To compare the regional cellular distribution of the 
mRNAs encoding the al-, ,&2- and ,&3-subunits in the 
CNS, in situ hybridization histochemistry on sections of 
rat brain was performed using oligodeoxynucleotide 
probes specific for each subunit. No specific hybridiza- 
tion was observed in myelinated regions such as the cor- 
pus callosum; in addition, no labeling above back- 
ground was detected using message sense probes as con- 
trols (data not shown). Our findings concur with, and 
extend those of others [9,24,25] in that mRNA en- 
coding GABAA receptor subunits is detectable in brain 
regions that also contain benzodiazepine and muscimol 
binding sites. ~yl mRNA was prominently expressed 
throughout the CNS, including neurons of the olfactory 
bulb, anterior olfactory nuclei, islands of Calleja, 
neocortex, globus pallidus, CAl-3 hippocampal pyram- 
idal cells, granule layer of the dentate gyrus, thalamic 
nuclei, inferior colliculus, geniculate nuclei, amygdala, 
pontine nuclei, cerebellum (granular, Purkinje and 
molecular cell layers) and cerebellar nuclei. Fig.3a il- 
lustrates labeling of a representative section through the 
parietal cortex, hippocampal formation and thalamic 
nuclei. In the cortex, a slight laminar distribution was 
evident; al mRNA was more prominent in laminae IV 
and VI. With few exceptions, the distribution of fl2 
mRNA (fig.3c,e) closely matched that of al transcripts. 
LOG [GABAI It.0 
Fig.2. Dose-response relationship for the activation of cloned 
GABAA receptors expressed in Xenopus oocytes. Oocytes expressing 
either cul/,K?- (0) or cul/@3- (m) subunits were perfused in the in- 
dicated concentrations of GABA for 2 min. Maximum current 
amplitude varied between 400-1300 nA. 
19 
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The most conspicuous fl3 mRNA levels were observ- 
ed in the cortex, caudate, hippocampal formation, 
medial habenula, periventricular thalamic nucleus, 
pyriform cortex, amygdalo-hippocampal area and 
cerebellum (fig.3b,d). Cortical labeling appeared more 
pronounced in the superficial and deeper layers. 
Notable differences in the distribution of fl2 and 83 
transcripts were apparent. For example, while ,62 
mRNA was expressed in the geniculate nucleus, globus 
pallidus, most thalamic nuclei and lateral cerebellar 
nuclei, ,63 mRNA was virtually undetectable in these 
areas. Thus, both LY- [9] and P-subunit subtypes appear 
to be heterogeneously expressed in the CNS. 
Fig.3. In situ hybridization histochemistry of coronal (a-c) and sagit- 
tal (d,e) rat brain sections with cul- (a), @2- (c,e) and,83- (b,d) subunit 
probes. Two probes for each subunit gave similar results. The il- 
lustrated sections approximately correspond to coronal level in- 
teraura15.7 mm and to sagittal evel lateral 3.4 mm as depicted in the 
work of Paxinos and Watson [26]. Regions rich in mRNA are light in 
the photomicrographs. CAlKA3, pyramidal cell layers of the hip- 
pocampus. CX, cortex; DC, dentate gyrus; Hbm, medial habenula; 
tpv, periventricular thalamic nuclei; ahi, amygdalo-hippocampal 
area; CPF, pyriform cortex; Hbl, lateral habenula; tl, lateral thalamic 
nuclei; tmd, medial dorsal thalamic nuclei; tvm, ventro medial 
thalamic nuclei; CPU, caudate putamen; CB, cerebellum; DLG, dor- 
solateral geniculate nucleus; GP, globus pallidus; Lat, lateral 
cerebellar nucleus. 
GABAA receptor complexes formed upon coexpres- 
sion of (Y- and &subunits possess many, but not all, of 
the functional properties of the native receptor ([7,&l l] 
and this report). Most noticeably, they do not demon- 
strate Hill coefficients close to 2.0 and they appear to 
lack the potentiation of response to GABA by ben- 
zodiazepines. Our data suggest that the GABA-sensi- 
tivity of the (Y/P complex appears to be conferred by the 
a- [7] and not the &subunit. The insensitivity to ben- 
zodiazepines may have been resolved by the recent clon- 
ing and expression of the cDNA for an additional 
GABAA receptor subunit, termed y2 [22]. Cotransfec- 
tion of y2-, al - and @l-subunit cDNAs into mammalian 
20 
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cells produce GABA* receptors which dispay high- 
affinity binding for central benzodiazepine receptor 
ligands .
GABAA receptor complexes with an cu/fl configura- 
tion may still be functionally relevant, since the binding 
sites for GABAA agonists and benzodiazepines are not 
always associated [23], and not all GABAA receptors 
are benzodiazepine-sensitive [19]. Our results with in 
situ hybridization histochemistry begin to address the 
heterogeneous distribution of (Y- and @subunits in the 
CNS. This regional specificity may reflect underlying 
functional variations such as dictating neuronal respon- 
siveness to GABAergic input. Further studies are 
underway to determine the cellular colocalization of in- 
dividual subunits that comprise functional GABAA 
receptor complexes. The use of subunit-specific probes 
at the in situ and cellular level opens the way for studies 
on the regulation of GABAA receptor gene expression 
to assess receptor synthesis in normal and pathological 
conditions. 
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